203 related articles for article (PubMed ID: 20089431)
1. Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity.
Kalla Singh S; Tan QW; Brito C; De León M; Garberoglio C; De León D
Growth Horm IGF Res; 2010 Apr; 20(2):162-70. PubMed ID: 20089431
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women.
Kalla Singh S; Tan QW; Brito C; De León M; De León D
Growth Horm IGF Res; 2010 Jun; 20(3):245-54. PubMed ID: 20347606
[TBL] [Abstract][Full Text] [Related]
3. Precursor IGF-II (proIGF-II) and mature IGF-II (mIGF-II) induce Bcl-2 And Bcl-X L expression through different signaling pathways in breast cancer cells.
Singh SK; Moretta D; Almaguel F; De León M; De León DD
Growth Factors; 2008 Apr; 26(2):92-103. PubMed ID: 18428028
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of proIGF-II and IGF-II on resveratrol induced cell death by regulating survivin cellular localization and mitochondrial depolarization in breast cancer cells.
Singh SK; Moretta D; Almaguel F; Wall NR; De León M; De León D
Growth Factors; 2007 Dec; 25(6):363-72. PubMed ID: 18365867
[TBL] [Abstract][Full Text] [Related]
5. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
Lund MJ; Trivers KF; Porter PL; Coates RJ; Leyland-Jones B; Brawley OW; Flagg EW; O'Regan RM; Gabram SG; Eley JW
Breast Cancer Res Treat; 2009 Jan; 113(2):357-70. PubMed ID: 18324472
[TBL] [Abstract][Full Text] [Related]
6. Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.
O'Driscoll L; Linehan R; M Kennedy S; Cronin D; Purcell R; Glynn S; W McDermott E; D Hill A; J O'Higgins N; Parkinson M; Clynes M
Cancer Lett; 2003 Nov; 201(2):225-36. PubMed ID: 14607338
[TBL] [Abstract][Full Text] [Related]
7. Expression of HER-2 in MCF-7 breast cancer cells modulates anti-apoptotic proteins Survivin and Bcl-2 via the extracellular signal-related kinase (ERK) and phosphoinositide-3 kinase (PI3K) signalling pathways.
Siddiqa A; Long LM; Li L; Marciniak RA; Kazhdan I
BMC Cancer; 2008 May; 8():129. PubMed ID: 18454859
[TBL] [Abstract][Full Text] [Related]
8. Molecular significance of excess body weight in postmenopausal breast cancer patients, in relation to expression of insulin-like growth factor I receptor and insulin-like growth factor II genes.
Suga K; Imai K; Eguchi H; Hayashi S; Higashi Y; Nakachi K
Jpn J Cancer Res; 2001 Feb; 92(2):127-34. PubMed ID: 11223541
[TBL] [Abstract][Full Text] [Related]
9. Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.
Oh H; Pfeiffer RM; Falk RT; Horne HN; Xiang J; Pollak M; Brinton LA; Storniolo AMV; Sherman ME; Gierach GL; Figueroa JD
Int J Cancer; 2018 Aug; 143(3):496-507. PubMed ID: 29473153
[TBL] [Abstract][Full Text] [Related]
10. Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3.
Fowke JH; Matthews CE; Yu H; Cai Q; Cohen S; Buchowski MS; Zheng W; Blot WJ
Endocr Relat Cancer; 2010 Mar; 17(1):51-60. PubMed ID: 19786462
[TBL] [Abstract][Full Text] [Related]
11. Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women.
Jung SY; Barrington WE; Lane DS; Chen C; Chlebowski R; Corbie-Smith G; Hou L; Zhang ZF; Paek MS; Crandall CJ
Menopause; 2017 Mar; 24(3):288-298. PubMed ID: 27749737
[TBL] [Abstract][Full Text] [Related]
12. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis.
Rückert F; Samm N; Lehner AK; Saeger HD; Grützmann R; Pilarsky C
BMC Cancer; 2010 Jul; 10():379. PubMed ID: 20646298
[TBL] [Abstract][Full Text] [Related]
14. Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
Gene; 2020 Dec; 763S():100030. PubMed ID: 34493366
[TBL] [Abstract][Full Text] [Related]
15. Differential expression and signaling activation of insulin receptor isoforms A and B: A link between breast cancer and diabetes.
Kalla Singh S; Brito C; Tan QW; De León M; De León D
Growth Factors; 2011 Dec; 29(6):278-89. PubMed ID: 21913804
[TBL] [Abstract][Full Text] [Related]
16. Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women.
Vadgama JV; Wu Y; Datta G; Khan H; Chillar R
Oncology; 1999 Nov; 57(4):330-40. PubMed ID: 10575321
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance contributes to racial disparities in breast cancer prognosis in US women.
Gallagher EJ; Fei K; Feldman SM; Port E; Friedman NB; Boolbol SK; Killelea B; Pilewskie M; Choi L; King T; Nayak A; Franco R; Cruz D; Antoniou IM; LeRoith D; Bickell NA
Breast Cancer Res; 2020 May; 22(1):40. PubMed ID: 32393319
[TBL] [Abstract][Full Text] [Related]
18. IGF-II mRNA expression in breast cancer: predictive value and relationship to other prognostic factors.
Fiore E; Campani D; Muller I; Belardi V; Giustarini E; Rossi G; Pinchera A; Giani C
Int J Biol Markers; 2010; 25(3):150-6. PubMed ID: 20677165
[TBL] [Abstract][Full Text] [Related]
19. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.
Gazzaniga P; Gradilone A; Giuliani L; Gandini O; Silvestri I; Nofroni I; Saccani G; Frati L; Aglianò AM
Ann Oncol; 2003 Jan; 14(1):85-90. PubMed ID: 12488298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]